Table 5:

Performance of the clinical chemistry score for identifying patients at low and high risk for myocardial infarction or death within 30 days after presentation to the emergency department*

Score cut-offNo. of participants with MI or who diedNo. of participants with no MI or death
CCS with hs-cTnI test
CCS > 07273140
CCS = 00378
Sensitivity, % (95% CI)100 (99.5–100)
NPV, % (95% CI)100 (98.9–100)
Negative likelihood ratio0 (0–0.05)
Patients at low risk, % (95% CI)8.9 (8.1–9.8)
CCS = 5358119
CCS < 53693399
Specificity, % (95% CI)96.6 (96.0–97.2)
PPV, % (95% CI)75.1 (71.3–78.5)
Positive likelihood ratio14.6 (12.0–17.6)
Patients at high risk, % (95% CI)11.2 (10.3–12.2)
CCS with hs-cTnT test
CCS > 07263075
CCS = 01443
Sensitivity, % (95% CI)99.9 (99.2–100)
NPV, % (95% CI)99.8 (98.4–100)
Negative likelihood ratio0.01 (0–0.06)
Patients at low risk, % (95% CI)10.5 (9.6–11.4)
CCS = 5342212
CCS < 53853306
Specificity, % (95% CI)94.0 (93.1–94.7)
PPV, % (95% CI)61.7 (58.1–65.2)
Positive likelihood ratio7.8 (6.7–9.1)
Patients at high-risk, % (95% CI)13.1 (12.1–14.1)
hs-cTnI test only
≥ 5 ng/L7021543
< 5 ng/L251975
Sensitivity, % (95% CI)96.6 (95.0–97.8)
NPV, % (95% CI)98.8 (98.2–99.2)
Negative likelihood ratio0.06 (0.04–0.09)
> 26 ng/L537239
≤ 26 ng/L1903279
Specificity, % (95% CI)93.2 (92.3–94.0)
PPV, % (95% CI)69.2 (65.8–72.4)
Positive likelihood ratio10.9 (9.6–12.4)
hs-cTnT test only
≥ 6 ng/L7142262
< 6 ng/L131256
Sensitivity, % (95% CI)98.2 (97.0–99.0)
NPV, % (95% CI)99.0 (98.3–99.5)
Negative likelihood ratio0.05 (0.03–0.09)
> 14 ng/L640922
≤ 14 ng/L872596
Specificity, % (95% CI)73.8 (72.3–75.2)
PPV, % (95% CI)41.0 (38.5–43.5)
Positive likelihood ratio3.4 (3.2–3.6)
  • Note: CCS = clinical chemistry score, CI = confidence interval, hs-cTnI = high-sensitivity cardiac troponin I, hs-cTnT = high-sensitivity cardiac troponin T, MI = myocardial infarction, NPV = negative predictive value, PPV = positive predictive value.

  • * Combined cohorts, n = 4245.

  • Unless specified otherwise.